PULMONX CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent
PULMONX CORPORATION (LUNG) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent of 0.00% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Expense Statement
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges · last filed 2022-03-01
- PULMONX CORPORATION effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for fiscal 2021 was 0.00%, a 100.00% decline from fiscal 2020.
- PULMONX CORPORATION effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for fiscal 2020 was 11.90%.
- PULMONX CORPORATION effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for fiscal 2019 was 0.00%.
- PULMONX CORPORATION effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for fiscal 2018 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent 12 month |
|---|---|
| 2021-12-31 | 0.00% 10-K · filed 2022-03-01 |
| 2020-12-31 | 11.90% 10-K · filed 2022-03-01 |
| 2019-12-31 | 0.00% 10-K · filed 2021-03-15 |
| 2018-12-31 | 0.00% 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |